MEA Cannabis Testing Market

MEA Cannabis Testing Market Size (2022 to 2027)

The size of the cannabis testing market in the Middle East & Africa was worth USD 79.87 Million in 2022. This value is further estimated to be growing at a CAGR of 13.1% and worth USD 147.81 Million by 2027.

Cannabis a banned for various social and political reasons in most countries since the early 1900s. Many countries are now recognizing the benefits of cannabis for medical purposes and have approved the use of cannabis. The growth of the cannabis testing market in the MEA is majorly driven by factors such as the legalization of medical marijuana, an increase in marijuana labs (particularly the United States), increased use of LIMS in marijuana labs, conferences, and discussions. Awareness-raising meetings and workshops are expected to create the need for analytical testing to ensure the safety of human food and the growth of the MEA cannabis testing market.

In the MEA Cannabis Testing Market, highly developed industries and a variety of mature emerging areas are creating a variety of market opportunities. Also, the mergers & acquisitions, partnerships, contracts, agreements, new product launches, etc., by key players to gain a competitive edge over other companies can help increase market demand. In addition, the increased demand for medicines and therapeutic cannabis is likely to expand market growth during the forecast period.

The high cost of analytical instruments, the presence of alternative technologies, and the lack of skilled professionals are critical factors that are supposed to limit the growth of the MEA Cannabis Testing Market in the future. Proper use of advanced analytical instruments requires relevant experience and knowledge of chromatography, spectroscopy, and PCR. In addition, lack of awareness of the choice of the right technology, especially in emerging economies, has created many other indirect costs, increasing the workload and time pressure on researchers. This limits the use of these technically advanced products in the laboratory. Also, the laboratories are expensive to start, and analytical equipment is costly.

This research report on the MEA cannabis testing market has been segmented and sub-segmented into the following categories:

By Testing Procedures:

• Terpene Profiling
• Potency Testing
• Residual Solvent Screening
• Pesticide Screening
• Genetic Testing
• Heavy Metal Testing
• Microbial Analysis

By End-user:

• Cannabis Cultivators
• Laboratories
• Drug Manufacturers & Dispensaries
• Research Institutes

By Product & Software:

• Analytical Instruments
• Consumables
• Software

By Country:

• KSA
• UAE
• Israel
• the rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the Middle East and Africa cannabis testing markets are still in their nascent stages in this region. However, factors such as the rising number of accidents under the influence of cannabis and its legalization for medical purposes in some parts of the world are expected to increase the growth of this market in the region.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the MEA cannabis testing market profiled in the report are Agilent Technologies, Inc., Shimadzu Corporation, Waters Corporation, PerkinElmer, Inc., AB SCIEX LLC, Millipore Sigma, Restek Corporation, LabLynx, Inc. (U.S.), Steep Hill Labs, Inc., PharmLabs, LLC, SC Laboratories, Inc., Digipath Labs, Inc., CannaSafe Analytics, and Accelerated Technology Laboratories, Inc.